[
  {
    "title": "百利天恒(688506.SH)将于1月6日在科创板上市",
    "href": "http://stock.jrj.com.cn/2023/01/04190537259257.shtml",
    "datetime": "2023-01-04 19:05:20",
    "code": "688506"
  },
  {
    "title": "百利天恒(688506.SH)披露发行结果：遭弃购117.5639万股、由主承销商包销",
    "href": "http://stock.jrj.com.cn/2022/12/29190937247284.shtml",
    "datetime": "2022-12-29 19:09:15",
    "code": "688506"
  },
  {
    "title": "百利天恒中签号出炉 共约2.06万个",
    "href": "http://stock.jrj.com.cn/ipo/2022/12/27191937241319.shtml",
    "datetime": "2022-12-27 19:19:43",
    "code": "688506"
  },
  {
    "title": "打新必读：百利天恒申购",
    "href": "http://stock.jrj.com.cn/ipo/2022/12/26080937236910.shtml",
    "datetime": "2022-12-26 08:09:51",
    "code": "688506"
  },
  {
    "title": "打新必看|12月26日百利天恒申购",
    "href": "http://stock.jrj.com.cn/ipo/2022/12/25204837236602.shtml",
    "datetime": "2022-12-25 20:48:01",
    "code": "688506"
  },
  {
    "title": "IPO打新观察：百利天恒发行价24.7元/股，弘毅远方基金、上海东证期货网下报价相差超55元",
    "href": "http://stock.jrj.com.cn/ipo/2022/12/23101837233403.shtml",
    "datetime": "2022-12-23 10:18:06",
    "code": "688506"
  },
  {
    "title": "百利天恒(688506.SH)IPO定价为24.7元/股、12月26日申购",
    "href": "http://stock.jrj.com.cn/2022/12/22201637232413.shtml",
    "datetime": "2022-12-22 20:16:57",
    "code": "688506"
  },
  {
    "title": "临门一脚？百利天恒冲刺科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2022/08/17104536907100.shtml",
    "datetime": "2022-08-17 10:45:48",
    "code": "688506"
  },
  {
    "title": "百利天恒科创板IPO通过审核，这些问题被问及",
    "href": "http://stock.jrj.com.cn/2022/07/29103836852964.shtml",
    "datetime": "2022-07-29 10:38:45",
    "code": "688506"
  },
  {
    "title": "科创板上市委：百利天恒首发获通过",
    "href": "http://stock.jrj.com.cn/2022/07/28195836851614.shtml",
    "datetime": "2022-07-28 19:58:01",
    "code": "688506"
  },
  {
    "title": "百利天恒药业：自我造血驱动研发创新 手握多特异性抗体和ADC重磅产品",
    "href": "http://stock.jrj.com.cn/2022/07/28105636849848.shtml",
    "datetime": "2022-07-28 10:56:38",
    "code": "688506"
  },
  {
    "title": "创业板改道科创板IPO，百利天恒7月28日迎上会",
    "href": "http://stock.jrj.com.cn/2022/07/22105836834998.shtml",
    "datetime": "2022-07-22 10:58:51",
    "code": "688506"
  },
  {
    "title": "百利天恒核心技术背离主营业务收入，疑不符合科创板上市标准，营收和毛利大幅双降，短期内四名独董连续离职",
    "href": "http://stock.jrj.com.cn/ipo/2022/07/14143636810931.shtml",
    "datetime": "2022-07-14 14:36:16",
    "code": "688506"
  },
  {
    "title": "是否属于带金销售？百利天恒答复科创板二轮问询",
    "href": "http://stock.jrj.com.cn/2022/06/29135536767543.shtml",
    "datetime": "2022-06-29 13:55:05",
    "code": "688506"
  },
  {
    "title": "亏损却坚持分红，应收账款高企，百利天恒因产品均价下滑创业板“失利”改道科创板上市",
    "href": "http://stock.jrj.com.cn/2021/11/18091133870695.shtml",
    "datetime": "2021-11-18 09:11:03",
    "code": "688506"
  },
  {
    "title": "百利天恒IPO：药品开发失败率高 净资产收益率下降",
    "href": "http://stock.jrj.com.cn/ipo/2014/07/01212917525069.shtml",
    "datetime": "2014-07-01 21:29:28",
    "code": "688506"
  }
]